Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,916 | 539 | 97.9% |
| Education | $129.41 | 4 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $1,182 | 115 | $0 (2024) |
| ABBVIE INC. | $1,000 | 88 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $784.66 | 75 | $0 (2024) |
| Janssen Biotech, Inc. | $638.89 | 60 | $0 (2024) |
| Allergan Inc. | $284.78 | 64 | $0 (2019) |
| Celgene Corporation | $231.07 | 25 | $0 (2024) |
| PFIZER INC. | $206.50 | 12 | $0 (2022) |
| Gilead Sciences, Inc. | $193.28 | 12 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $132.06 | 5 | $0 (2024) |
| UCB, Inc. | $116.49 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,426 | 88 | ABBVIE INC. ($279.00) |
| 2023 | $701.34 | 52 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($289.26) |
| 2022 | $550.62 | 54 | ABBVIE INC. ($131.46) |
| 2021 | $446.48 | 33 | AbbVie Inc. ($145.52) |
| 2020 | $352.50 | 22 | AbbVie Inc. ($71.82) |
| 2019 | $846.67 | 113 | Takeda Pharmaceuticals U.S.A., Inc. ($189.94) |
| 2018 | $1,132 | 130 | Takeda Pharmaceuticals U.S.A., Inc. ($545.39) |
| 2017 | $589.05 | 51 | AbbVie, Inc. ($176.83) |
All Payment Transactions
543 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $42.51 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/10/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Rare Disease | ||||||
| 12/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Rare Disease | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: LIVER DISEASE | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $3.16 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 187 | 260 | $26,305 | $16,443 |
| 2022 | 8 | 297 | 361 | $36,774 | $21,450 |
| 2021 | 8 | 349 | 428 | $41,736 | $26,471 |
| 2020 | 6 | 352 | 447 | $42,309 | $22,337 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 193 | $18,335 | $11,762 | 64.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 26 | $3,900 | $2,433 | 62.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $2,990 | $1,593 | 53.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 18 | $1,080 | $655.26 | 60.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 163 | $15,485 | $9,812 | 63.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $5,200 | $2,820 | 54.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 29 | $4,350 | $2,587 | 59.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 28 | 32 | $3,520 | $2,061 | 58.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $2,574 | $1,467 | 57.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 31 | 37 | $2,405 | $1,383 | 57.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 19 | $1,140 | $733.02 | 64.3% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 28 | 28 | $2,100 | $588.64 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 135 | 193 | $18,335 | $12,311 | 67.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 59 | 59 | $7,670 | $4,686 | 61.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 36 | 41 | $3,970 | $2,714 | 68.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 43 | 55 | $3,515 | $2,201 | 62.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 26 | $3,636 | $2,054 | 56.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 16 | $2,075 | $1,456 | 70.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 20 | 21 | $1,260 | $726.58 | 57.7% |
| 91200 | Measuring the stiffness in the liver via elastography | Office | 2021 | 16 | 17 | $1,275 | $322.01 | 25.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 138 | 211 | $20,045 | $10,866 | 54.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 88 | 88 | $11,440 | $6,045 | 52.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 34 | $4,284 | $2,426 | 56.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 56 | 64 | $3,840 | $1,986 | 51.7% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 25 | 30 | $1,200 | $507.27 | 42.3% |
About Dr. David Tabor, DO
Dr. David Tabor, DO is a Internal Medicine healthcare provider based in Wyoming, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720097231.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Tabor, DO has received a total of $6,045 in payments from pharmaceutical and medical device companies, with $1,426 received in 2024. These payments were reported across 543 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($5,916).
As a Medicare-enrolled provider, Tabor has provided services to 1,185 Medicare beneficiaries, totaling 1,496 services with total Medicare billing of $86,700. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wyoming, MI
- Active Since 08/05/2006
- Last Updated 07/15/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720097231
Products in Payments
- XIFAXAN (Drug) $681.39
- Amitiza (Drug) $584.22
- STELARA (Biological) $576.93
- ENTYVIO (Biological) $366.69
- LINZESS (Drug) $352.96
- ZEPOSIA (Drug) $231.07
- CREON (Drug) $199.30
- DUPIXENT (Biological) $156.37
- TRULANCE (Drug) $139.53
- Humira (Biological) $138.95
- Entyvio (Biological) $132.79
- XELJANZ (Drug) $130.59
- Creon (Drug) $128.30
- HUMIRA (Biological) $117.57
- Cimzia (Drug) $116.49
- ZENPEP (Drug) $105.26
- OCALIVA (Drug) $93.70
- RINVOQ (Biological) $89.95
- MAVYRET (Drug) $82.91
- TREMFYA (Drug) $61.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wyoming
Mounir Ghali, M.d, M.D
Internal Medicine — Payments: $363,968
Dr. Michael Sumners, D.o, D.O
Internal Medicine — Payments: $9,438
Dr. Gunjan Gholkar, M.d, M.D
Internal Medicine — Payments: $7,082
Dr. Soheil Assar, Do, DO
Internal Medicine — Payments: $2,492
Dr. Lucas Watts, D.o, D.O
Internal Medicine — Payments: $1,807
Gabriel Pedraza, Md, MD
Internal Medicine — Payments: $1,803